IL15 and influenza: These results suggest the potential for IL-15 augmentation of adjuvant to overcome immunodominance of influenza HA head region epitopes as a potential vaccine boosting strategy to increase levels of broadly cross-reactive anti-influenza HA IgG antibodies.